We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

388:HKEXHong Kong Exchanges & Clearing Ltd. Analysis

Data as of 2026-06-14 - not real-time

MYR 0.85

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Muda Holdings is trading just above its recent support level, with the 20‑day moving average slipping slightly beneath the 50‑day average, hinting at a modest bearish bias. The RSI hovers around the mid‑point, suggesting the stock is neither overbought nor oversold, while the MACD line sits below its signal, reinforcing a bearish technical signal. Volume has been on the rise, providing some liquidity support, but price remains constrained near the upper end of its 52‑week range, facing a clear resistance ceiling.
Fundamentally, the company reports negative profit margins and earnings per share, a high debt load relative to equity, and a low return on equity, all of which weigh on its financial health. Nevertheless, the valuation appears extremely cheap, with price‑to‑book and price‑to‑sales ratios well below one, and a dividend yield in the mid‑single digits supported by a payout ratio under 70%. The combination of cheap valuation and dividend income offers a modest cushion, but the structural profitability challenges and leverage keep upside limited in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram
  • Price testing resistance near recent highs
  • Increasing volume but limited upside

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Very low price‑to‑book and price‑to‑sales ratios
  • Negative earnings and high leverage
  • Dividend yield offering modest income

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Deep valuation discount provides margin of safety
  • Potential for operational turnaround to improve margins
  • Sustained dividend can support total return if profitability recovers

Key Metrics & Analysis

Financial Health

Revenue Growth-7.50%
Profit Margin-1.95%
ROE-1.95%
ROA-0.37%
Debt/Equity56.14
P/B Ratio0.2
Op. Cash FlowMYR60.5M
Free Cash FlowMYR10.1M

Technical Analysis

TrendNeutral
RSI49.5
SupportMYR 0.81
ResistanceMYR 0.88
MA 20MYR 0.84
MA 50MYR 0.87
MA 200MYR 0.82
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

GradeUndervalued
TypeValue
Dividend Yield2.35%

Risk Assessment

Beta0.16
Volatility44.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.